...
首页> 外文期刊>BMC Pregnancy and Childbirth >Induction of labour versus expectant management in women with preterm prelabour rupture of membranes between 34 and 37 weeks (the PPROMEXIL-trial)
【24h】

Induction of labour versus expectant management in women with preterm prelabour rupture of membranes between 34 and 37 weeks (the PPROMEXIL-trial)

机译:早产前胎膜破裂妇女在34至37周之间引产与预期管理的比较(PPROMEXIL试验)

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background Preterm prelabour rupture of the membranes (PPROM) is an important clinical problem and a dilemma for the gynaecologist. On the one hand, awaiting spontaneous labour increases the probability of infectious disease for both mother and child, whereas on the other hand induction of labour leads to preterm birth with an increase in neonatal morbidity (e.g., respiratory distress syndrome (RDS)) and a possible rise in the number of instrumental deliveries. Methods/Design We aim to determine the effectiveness and cost-effectiveness of immediate delivery after PPROM in near term gestation compared to expectant management. Pregnant women with preterm prelabour rupture of the membranes at a gestational age from 34+0 weeks until 37+0 weeks will be included in a multicentre prospective randomised controlled trial. We will compare early delivery with expectant monitoring. The primary outcome of this study is neonatal sepsis. Secondary outcome measures are maternal morbidity (chorioamnionitis, puerperal sepsis) and neonatal disease, instrumental delivery rate, maternal quality of life, maternal preferences and costs. We anticipate that a reduction of neonatal infection from 7.5% to 2.5% after induction will outweigh an increase in RDS and additional costs due to admission of the child due to prematurity. Under these assumptions, we aim to randomly allocate 520 women to two groups of 260 women each. Analysis will be by intention to treat. Additionally a cost-effectiveness analysis will be performed to evaluate if the cost related to early delivery will outweigh those of expectant management. Long term outcomes will be evaluated using modelling. Discussion This trial will provide evidence as to whether induction of labour after preterm prelabour rupture of membranes is an effective and cost-effective strategy to reduce the risk of neonatal sepsis. Controlled clinical trial register ISRCTN29313500
机译:背景技术胎膜早破(PPROM)是一个重要的临床问题,也是妇科医生的难题。一方面,等待自发性分娩会增加母婴传染病的可能性,另一方面,引产会导致早产,新生儿发病率增加(例如呼吸窘迫综合征(RDS)),工具交付的数量可能会增加。方法/设计我们的目标是确定与预期管理相比,PPROM短期妊娠后立即分娩的有效性和成本效益。多中心前瞻性随机对照试验包括胎龄早早从34 +0 周到37 +0 周的孕妇。我们会将早期交付与预期监控进行比较。这项研究的主要结果是新生儿败血症。次要结果指标是母亲的发病率(绒毛膜羊膜炎,产后脓毒症)和新生儿疾病,分娩率,母亲的生活质量,母亲的喜好和费用。我们预计,诱导后新生儿感染率从7.5%降低到2.5%,将超过RDS的增加以及由于早产导致儿童入院而产生的额外费用。根据这些假设,我们旨在将520名女性随机分配给两组,每组260名女性。分析将按意向进行。此外,将进行成本效益分析,以评估与提早交付相关的成本是否超过预期管理的成本。长期结果将通过建模进行评估。讨论该试验将提供证据,证明早产胎膜早破后引产是否是降低新生儿败血症风险的有效且具有成本效益的策略。受控临床试验注册簿ISRCTN29313500

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号